The Lipid Hydrolase ABHD6 is a Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Hepatocellular Carcinoma
脂质水解酶ABHD6是代谢功能障碍相关脂肪肝病(MASLD)相关肝细胞癌的治疗靶点
期刊:
影响因子:
doi:10.1101/2025.07.29.667509
Orabi, Danny; Massey, William J; Fung, Kevin K; Varadharajan, Venkateshwari; Ramachandiran, Iyappan; Banerjee, Rakhee; Silver, Daniel J; Osborn, Lucas J; Brown, Amanda L; Marshall, Stephanie; Ferguson, Daniel; Cao, Shijie; Schugar, Rebecca C; Finney, Chelsea; Neumann, Chase; Burrows, Amy C; Horak, Anthony J; Pathak, Preeti; Helsley, Robert N; Bulfon, Dominik; Zimmermann, Robert; Leung, Yat Hei; Madiraju, S R Murthy; Prentki, Marc; Lee, Richard G; Mullick, Adam E; Zergeeva, Olga; Dasarathy, Srinivasan; Lee, Zhenghong; Allende, Daniela S; Aucejo, Federico; Lathia, Justin D; Brown, J Mark